Dr. Sharda to present about the bleeding challenges of Hermansky-Pudlak Syndrome at the 24th Annual HPS Conference

Feb 9, 2017

Dr. Anish Sharda, a researcher working on the bleeding problems associated with Hermansky-Pudlak Syndrome, will be a speaker on Science Sunday, March 12 at the 24th Annual HPS Network Conference at the Long Island Marriott in Uniondale, NY.

Dr. Sharda is an Instructor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. Originally from central India, he obtained M.B., B.S. from B P Koirala Institute of Health Sciences, Nepal. After completing residency training in Internal Medicine at the University of Minnesota, he joined the Hematology/Oncology fellowship program at Beth Israel Deaconess Medical Center in 2011. He has been a research fellow in the laboratories of Dr. Bruce Furie and Dr. Robert Flaumenhaft since 2012.

Dr. Sharda’s research has primarily focused on the role of platelet dense granules in thrombus formation. Currently, he is studying the molecular mechanisms underlying endothelial release of von Willebrand factor. Specifically, he is evaluating the role played by Hermansky-Pudlak Syndrome 6 protein and its partners in Weibel-Palade body biogenesis, and maturation and release of von Willebrand factor. As a clinician, he specializes in bleeding and clotting disorders, including platelet and rare bleeding disorders.